《JMV,2月28日,Clinical trial analysis of 2019‐nCoV therapy registered in China》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-01
  • Clinical trial analysis of 2019‐nCoV therapy registered in China

    Qi Zhang Yakun Wang Changsong Qi Lin Shen Jian Li

    First published:28 February 2020 https://doi.org/10.1002/jmv.25733

    Abstract

    So far, there is a lack of effective drugs for the new coronavirus pneumonia. With more and more patients diagnosed, China has carried out more than one hundred clinical studies of new coronavirus infection, including antiviral drugs, antimalarial drugs, glucocorticoids, plasma therapy, virus vaccine and other western drugs, while Chinese medicine researches accounted for half of studies. Most of the trials were initiated by investigators and the study period would last for one to eleven months. The primary endpoints included symptom improvement and virus nucleic acid turning negative, but the optimal endpoint has not been determined. Although the final results of studies will take a long time to complete, the interim research data may provide some help for the current urgent demand for drug treatment. Compared with that of during SARS period in 2003, China have the stronger capability to carry out clinical trials of new drugs in emergency period.

  • 原文来源:https://doi.org/10.1002/jmv.25733
相关报告
  • 《JMV,2月28日,Clinical characteristics of 50466 hospitalized patients with 2019‐nCoV infection》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-01
    • Clinical characteristics of 50466 hospitalized patients with 2019‐nCoV infection Pengfei Sun MD Shuyan Qie MD Zongjan Liu MD Jizhen Ren MD Kun Li MD Jianing Xi MD First published:28 February 2020 https://doi.org/10.1002/jmv.25735 Abstract Objective We aim to summarize reliable evidences of evidence‐based medicine for the treatment and prevention of the 2019 novel coronavirus (2019‐nCoV) by analyzing all the published studies on the clinical characteristics of patients with 2019‐nCoV. Methods PubMed, Cochrane Library, Embase, and other databases were searched. Several studies on the clinical characteristics of 2019‐nCoV infection were collected for Meta‐analysis.
  • 《SSRN,2月28日,Key Points of Clinical and CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) Imported Pneumonia Based on 21 Cases Analysis》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-29
    • Key Points of Clinical and CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) Imported Pneumonia Based on 21 Cases Analysis 19 Pages Posted: 28 Feb 2020 Zhifeng Xu Government of the People's Republic of China - Department of Radiology Wenxiu Wu Government of the People's Republic of China - Department of Radiology Abstract Background and Objective: WHO Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern,and the outbreak is still on-going.Chest CT had been a key component of the diagnostic workup for patients with suspected infection. In this retrospective study, we attempt to summarize and analyze the chest CT features of 2019-nCov infections, and to identify the typical features to improved the diagnostic accuracy of new coronavirus pneumonia (NCP).